Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases

Bibliography

• Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-62
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Canonica GW. Long-lasting clinical efficacy of allergen specific immunotherapy. Allergy 2002;10:275-6
   Web of Science ®Google Scholar
• Des Roches A, Paradis L, Menardo JL, Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-3
   PubMed Web of Science ®Google Scholar
• Pajno GB, Barberio G, De Luca F, Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-7
   PubMed Web of Science ®Google Scholar
• Purello-D'Ambrosio F, Gangemi S, Merendino RA, Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31:1295-302
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-8
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7
   PubMed Web of Science ®Google Scholar
• Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-7
   PubMed Web of Science ®Google Scholar
• Lower T, Henry J, Mandik L, Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-2
   PubMedGoogle Scholar
• More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol 2002;88:391-4
   PubMed Web of Science ®Google Scholar
• Bousquet J, Hejjaoui A, Soussana M, Michel FBDouble-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-7
   PubMed Web of Science ®Google Scholar
• Lilja G, Sundin B, Graff-Lonnevig V, Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment. J Allergy Clin Immunol 1989;83:37-44
   PubMed Web of Science ®Google Scholar
• Hejjaoui A, Dhivert H, Michel FB, Bousquet JImmunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473-9
   PubMed Web of Science ®Google Scholar
• Portnoy J, Bagstad K, Kanarek H, Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy 1994;73:409-18
   PubMedGoogle Scholar
• Bousquet J, Michel FB. Safety considerations in assessing the role of immunotherapy in allergic disorders. Drug Saf 1994;10:5-17
   PubMed Web of Science ®Google Scholar
• Goldberg A, Confino-Cohen R. Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy. Ann Allergy Asthma Immunol 2003;91:405-10
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Ann Allergy 1994;73(5):423-8
   PubMedGoogle Scholar
• Moreno C, Cuesta-Herranz J, Fernandez-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004;34:527-31
   PubMed Web of Science ®Google Scholar
• Alvarez-Cuesta E, Bousquet J, Canonica GW, Standards for practical allergen-specific immunotherapy. Allergy 2006;61(Suppl 82):1-20
   PubMed Web of Science ®Google Scholar
• Pfaar O, Leitzbach S, Hormann K, Klimek L. Cluster protocols in SCIT: enough evidence for practical use? Curr Opin Allergy Clin Immunol 2010;10:188-93
   PubMed Web of Science ®Google Scholar
• Pereira EA, Silva DA, Cunha-Junior JP, IgE, IgG1, and IgG4 antibody responses to Blomia tropicalis in atopic patients. Allergy 2005;60(3):401-6
   PubMed Web of Science ®Google Scholar
• Soyer OU, Akdis M, Akdis CA. Mechanisms of subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 2011;31(2):175-90
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007;119(4):881-91
   PubMed Web of Science ®Google Scholar
• Nouri-Aria KT, Wachholz PA, Francis JN, Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004;172(5):3252-9
   PubMed Web of Science ®Google Scholar
• Charpin D, Gouitaa M, Dron-Gonzalvez M, Immunotherapy with an aluminum hydroxide-adsorbed Juniperus ashei foreign pollen extract in seasonal indigenous cypress pollen rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;143:83-91
   PubMed Web of Science ®Google Scholar
• Pauli G, Larsen TH, Rak S, Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008;122(5):951-60
   PubMed Web of Science ®Google Scholar
• Wuthrich B, Gumowski PL, Fah J, Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide. J Investig Allergol Clin Immunol 2001;11(3):149-56
   PubMed Web of Science ®Google Scholar
• Gardner LM, Thien FC, Douglass JA, Induction of T ‘regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004;34(8):1209-19
   PubMed Web of Science ®Google Scholar
• Horst M, Hejjaoui A, Horst V, Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85(2):460-72
   PubMed Web of Science ®Google Scholar
• Pfaar O, Klimek L, Fischer I, Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Int Arch Allergy Immunol 2009;150:102-8
   PubMed Web of Science ®Google Scholar
• Serrano P, Justicia JL, Sanchez C, Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Ann Allergy Asthma Immunol 2009;102:247-52
   PubMed Web of Science ®Google Scholar
• Quiralte J, Cardona V, Davila I, Short conventional versus cluster immunotherapy for respiratory allergies: a retrospective safety comparison. 29th Congress of the EAACI; 5 – 9 June 2010; London, United Kingdom
   Google Scholar
• Valero A, Justicia JL, Anton E, Epidemiology of allergic rhinitis due to grass pollen or house dust mites in Spain. Am J Rhinol Allergy 2011;25:123-8
   PubMed Web of Science ®Google Scholar
• Ibero M, Justicia JL, Alvaro M, Diagnosis and treatment of allergic rhinitis in children: results of the PETRA study. Allergol Immunopathol (Madr); 2011. doi: 10.1016/j.aller.2010.12.010
   Web of Science ®Google Scholar
• Cox L. Advantages and disadvantages of accelerated immunotherapy schedules. J Allergy Clin Immunol 2008;122:432-4
   PubMed Web of Science ®Google Scholar
• Tabar AI, Echechipia S, Garcia BE, Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-18
   PubMed Web of Science ®Google Scholar
• Mauro M, Russello M, Alesina R, Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one. Eur Ann Allergy Clin Immunol 2006;38:31-4
   PubMedGoogle Scholar